{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:33:07Z","timestamp":1722889987246},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Japan Agency for Medical Research and Development, AMED"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10157-017-1528-0","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T07:55:06Z","timestamp":1515743706000},"page":"850-859","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Glucosuria and all-cause mortality among general screening participants"],"prefix":"10.1007","volume":"22","author":[{"name":"For the \u201cDesign of the Comprehensive Health Care System for Chronic Kidney Disease (CKD) Based on the Individual Risk Assessment by Specific Health Check\u201d","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunitoshi","family":"Iseki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneo","family":"Konta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Asahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouichi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Tsuruya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugo","family":"Shibagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiho","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,12]]},"reference":[{"key":"1528_CR1","unstructured":"http:\/\/www.jsdt.or.jp\n                    \n                  ."},{"key":"1528_CR2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s10157-011-0551-9","volume":"16","author":"K Iseki","year":"2012","unstructured":"Iseki K, Asahi K, Moriyama T, et al. Risk factor profiles based on eGFR and dipstick proteinuria: analysis of the participants of the Specific Health Check and Guidance System in Japan 2008. Clin Exp Nephrol. 2012;16:244\u20139.","journal-title":"Clin Exp Nephrol"},{"key":"1528_CR3","doi-asserted-by":"publisher","unstructured":"Iseki K, Asahi K, Yamagata K, et al. Mortality risk among screened subjects of the Specific Health Check and Guidance Program in Japan 2008\u20132012. Clin Exp Nephrol. 2017. \n                    https:\/\/doi.org\/10.1007\/s10157-017-1392-y\n                    \n                  . (Epub ahead of print).","DOI":"10.1007\/s10157-017-1392-y"},{"key":"1528_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx213","author":"K Iseki","year":"2017","unstructured":"Iseki K, Konta T, Asahi K, et al. Association of dipstick hematuria with all-cause mortality in the general population: results from the Specific Health Check and Guidance Program in Japan. Nephrol Dial Transpl. 2017. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfx213\n                    \n                  . (Epub ahead of print).","journal-title":"Nephrol Dial Transpl"},{"key":"1528_CR5","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/sj.ki.5000194","volume":"59","author":"J Calado","year":"2006","unstructured":"Calado J, Loeffler J, Sakallioglu O, et al. Familial renal glucosuria: SLC5A2 mutation analysis and evidence of salt-wasting. Kidney Int. 2006;59:852\u20135.","journal-title":"Kidney Int"},{"key":"1528_CR6","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1093\/ndt\/gfs493","volume":"27","author":"SK Haque","year":"2012","unstructured":"Haque SK, Ariceta G, Batlle D. Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol Dial Transpl. 2012;27:4273\u201387.","journal-title":"Nephrol Dial Transpl"},{"issue":"22","key":"1528_CR7","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117\u201328.","journal-title":"N Engl J Med"},{"issue":"4","key":"1528_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med. 2016;375(4):323\u201334.","journal-title":"N Engl J Med"},{"key":"1528_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrneph.2016.170","volume":"13","author":"RA DeFronzo","year":"2017","unstructured":"DeFronzo RA, Norton L, Abdul-Ghani M. Renal, metabolic and cardiovascular considerations of SGLT2 inhibition. Nat Rev Nephrol. 2017;13:11\u201326.","journal-title":"Nat Rev Nephrol"},{"key":"1528_CR10","doi-asserted-by":"publisher","first-page":"39372","DOI":"10.1038\/srep39372","volume":"6","author":"CC Hung","year":"2016","unstructured":"Hung CC, Lin HYH, Lee JJ, et al. Glycosuria and renal outcomes in patients with nondiabetic advanced chronic kidney disease. Sci Rep. 2016;6:39372.","journal-title":"Sci Rep"},{"issue":"6","key":"1528_CR11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982\u201392.","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 1","key":"1528_CR12","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc11-S062","volume":"34","author":"American Diabetes Association","year":"2011","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34(Suppl 1):S62\u2013S69.","journal-title":"Diabetes Care"},{"issue":"10","key":"1528_CR13","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1093\/ndt\/gfs324","volume":"27","author":"Y Sato","year":"2012","unstructured":"Sato Y, Yano Y, Fujimoto S, et al. Glycohemoglobin not as predictive as fasting glucose as a measure of prediabetes in predicting proteinuria. Nephrol Dial Transpl. 2012;27(10):3862\u20138.","journal-title":"Nephrol Dial Transpl"},{"issue":"S2","key":"1528_CR14","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1089\/dia.2017.0013","volume":"19","author":"RA Lal","year":"2017","unstructured":"Lal RA, Maahs DM. Clinical use of continuous glucose monitoring in pediatrics. Diabetes Technol Ther. 2017;19(S2):S37\u2013S43.","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"1528_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrendo.2017.3","volume":"13","author":"BP Kovatchev","year":"2017","unstructured":"Kovatchev BP. Metrics for glycaemic control\u2014from HbA1c to continuous glucose monitoring. Nat Rev Endocrinol. 2017;13(7):425\u201336.","journal-title":"Nat Rev Endocrinol"},{"key":"1528_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1464-5491.1993.tb00036.x","volume":"10","author":"DK Andersson","year":"1993","unstructured":"Andersson DK, Lundblad E, Svardsudd K. A model for early diagnosis of type 2 diabetes mellitus in primary health care. Diabetes Med. 1993;10:167\u201373.","journal-title":"Diabetes Med"},{"issue":"6","key":"1528_CR17","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10157-014-0943-8","volume":"18","author":"M Kondo","year":"2014","unstructured":"Kondo M, Yamagata K, Hoshi SL, et al. Budget impact analysis of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2014;18(6):885 \u2013 91.","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"1528_CR18","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10552-017-0884-0","volume":"28","author":"M Nagai","year":"2017","unstructured":"Nagai M, Murakami Y, Tamakoshi A, et al. Fasting but not casual blood glucose is associated with pancreatic cancer mortality in Japanese: EPOCH-JAPAN. Cancer Causes Control. 2017;28(6):625\u201333.","journal-title":"Cancer Causes Control"},{"key":"1528_CR19","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.kint.2016.09.010","volume":"90","author":"V Perkovic","year":"2016","unstructured":"Perkovic V, Agarwal R, Fioretto P, et al. Management of patients with diabetes and CKD: conclusions from a \u201cKidney Disease: improving Global Outcomes\u201d (KDIGO) Controversies Conference. Kidney Int. 2016;90:1175\u201383.","journal-title":"Kidney Int"},{"key":"1528_CR20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jdiacomp.2015.04.014","volume":"29","author":"JY Wang","year":"2015","unstructured":"Wang JY, Yang JH, Xu J, et al. Renal tubular damage may contribute more to acute hyperglycemia induced kidney injury in non-diabetic conscious rats. J Diabetes Complicat. 2015;29:621\u20138.","journal-title":"J Diabetes Complicat"},{"issue":"Suppl 4","key":"1528_CR21","doi-asserted-by":"publisher","first-page":"iv60","DOI":"10.1093\/ndt\/gfv264","volume":"30","author":"J Slyne","year":"2015","unstructured":"Slyne J, Slattery C, McMorrow T, et al. New developments concerning the proximal tubule in diabetic nephropathy: in vitro models and mechanisms. Nephrol Dial Transpl. 2015;30(Suppl 4):iv60\u2013i67.","journal-title":"Nephrol Dial Transpl"},{"key":"1528_CR22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1681\/ASN.2013090990","volume":"26","author":"L Nordquist","year":"2015","unstructured":"Nordquist L, Friederich-Persson M, Fasching A, et al. Activation of hypoxia-inducible factors prevents diabetic nephropathy. J Am Soc Nephrol. 2015;26:328 \u2013 38.","journal-title":"J Am Soc Nephrol"},{"key":"1528_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1053\/j.jrn.2014.10.020","volume":"25","author":"SC Tang","year":"2015","unstructured":"Tang SC, Yiu WH, Lin M, et al. Diabetic nephropathy and proximal tubular damage. J Ren Nutr. 2015;25:230\u20133.","journal-title":"J Ren Nutr"},{"key":"1528_CR24","doi-asserted-by":"publisher","first-page":"e100777","DOI":"10.1371\/journal.pone.0100777","volume":"9","author":"N Terami","year":"2014","unstructured":"Terami N, Ogawa D, Tachibana H, et al. Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db\/db mice. PLoS One. 2014;9:e100777.","journal-title":"PLoS One"},{"key":"1528_CR25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611925","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1611925\n                    \n                  . (Epub ahead of print).","journal-title":"N Engl J Med"},{"issue":"suppl","key":"1528_CR26","first-page":"S59-S67","volume":"120","author":"C Wanner","year":"2017","unstructured":"Wanner C. EMPA-REG outcome: the nephrologist\u2019s point of view. Am J Cardiol. 2017;120(suppl):S59-S67.","journal-title":"Am J Cardiol"},{"key":"1528_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwx047","author":"M Wakisaka","year":"2017","unstructured":"Wakisaka M, Nagao T. Sodium glucose cotransporter 2 in mesangial cells and retinal pericytes and its implications for diabetic nephropathy and retinopathy. Glycobiology. 2017. \n                    https:\/\/doi.org\/10.1093\/glycob\/cwx047\n                    \n                  . (Epub ahead of print).","journal-title":"Glycobiology"},{"key":"1528_CR28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.7326\/M14-2221","volume":"162","author":"S Selph","year":"2015","unstructured":"Selph S, Dana T, Blazina I, et al. Screening for type 2 diabetes mellitus: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2015;162:765\u201376.","journal-title":"Ann Intern Med"},{"issue":"9","key":"1528_CR29","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMc1602469","volume":"375","author":"L Zhang","year":"2016","unstructured":"Zhang L, Long J, Jiang W, et al. Trends in chronic kidney disease in China. N Engl J Med. 2016;375(9):905\u20136.","journal-title":"N Engl J Med"},{"key":"1528_CR30","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","volume":"23","author":"N Barzilai","year":"2016","unstructured":"Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA. Metformin as a tool to target aging. Cell Matb. 2016;23:1060\u20135.","journal-title":"Cell Matb"},{"key":"1528_CR31","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1007\/s00125-017-4337-9","volume":"60","author":"SJ Griffin","year":"2017","unstructured":"Griffin SJ, Leaver JK, Irving GJ. Impact of metformin on cardiovascular disease: a meta-analysis of randomized trials among people with type 2 diabetes. Diabetologia. 2017;60:1620\u20139.","journal-title":"Diabetologia"},{"issue":"2","key":"1528_CR32","first-page":"83","volume":"32","author":"CU Kocogullari","year":"2017","unstructured":"Kocogullari CU, Kunt AT, Aksoy R, et al. Hemoglobin A1c predicts acute kidney injury after coronary artery bypass surgery in non-diabetic patients. Braz J Cardiovasc Surg. 2017;32(2):83 \u2013 9.","journal-title":"Braz J Cardiovasc Surg"},{"issue":"6","key":"1528_CR33","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.kint.2016.10.046","volume":"91","author":"AS Krolewski","year":"2017","unstructured":"Krolewski AS, Skupien J, Rossing P, et al. Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes. Kidney Int. 2017;91(6):1300\u201311.","journal-title":"Kidney Int"},{"key":"1528_CR34","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.2215\/CJN.06511208","volume":"4","author":"H Yokoyama","year":"2009","unstructured":"Yokoyama H, Kanno S, Takahashi S, et al. Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension. Clin J Am Soc Nephrol. 2009;4:1432\u201340.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1528_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw417","author":"K Furuichi","year":"2017","unstructured":"Furuichi K, Yuzawa Y, Shimizu M, et al. Nationwide multicenter kidney biopsy study of Japanese patients with type 2 diabetes. Nephrol Dial Transpl. 2017. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfw417\n                    \n                  . (Epub ahead of print).","journal-title":"Nephrol Dial Transpl"},{"key":"1528_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13093","author":"T Usui","year":"2017","unstructured":"Usui T, Kanda E, Iseki C, et al. Observation period for changes in proteinuria and risk prediction of end-stage renal disease in general population. Nephrology. 2017. \n                    https:\/\/doi.org\/10.1111\/nep.13093\n                    \n                  . (Epub ahead of print).","journal-title":"Nephrology"},{"key":"1528_CR37","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10157-013-0879-4","volume":"18","author":"T Wada","year":"2014","unstructured":"Wada T, Haneda M, Furuichi K, et al. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol. 2014;18:613\u201320.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"1528_CR38","doi-asserted-by":"publisher","first-page":"e0151422","DOI":"10.1371\/journal.pone.0151422","volume":"11","author":"K Yamagata","year":"2016","unstructured":"Yamagata K, Makino H, Iseki K, et al. Effect of behavior modification on outcome in early- to moderate-stage chronic kidney disease: a cluster-randomized trial. PLoS One. 2016;11(3):e0151422.","journal-title":"PLoS One"},{"issue":"4","key":"1528_CR39","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2337\/diacare.16.4.570","volume":"16","author":"A Sekikawa","year":"1993","unstructured":"Sekikawa A, Tominaga M, Takahashi K, et al. Prevalence of diabetes and impaired glucose tolerance in Funagata area, Japan. Diabetes Care. 1993;16(4):570\u20134.","journal-title":"Diabetes Care"},{"issue":"6","key":"1528_CR40","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/diacare.22.6.920","volume":"22","author":"M Tominaga","year":"1999","unstructured":"Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care. 1999;22(6):920\u20134.","journal-title":"Diabetes Care"},{"key":"1528_CR41","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1681\/ASN.2006010097","volume":"17","author":"PE Jong de","year":"2006","unstructured":"de Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria: public health perspectives. J Am Soc Nephrol. 2006;17:2120\u20136.","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-017-1528-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-017-1528-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-017-1528-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T00:46:58Z","timestamp":1547254018000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-017-1528-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,12]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1528"],"URL":"https:\/\/doi.org\/10.1007\/s10157-017-1528-0","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"type":"print","value":"1342-1751"},{"type":"electronic","value":"1437-7799"}],"subject":[],"published":{"date-parts":[[2018,1,12]]},"assertion":[{"value":"5 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were performed in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (Fukushima Medical University; IRB Approval Number #1485, #2771) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study was performed according to Ethical Guidelines for Medical and Health Research Involving Human Subjects enacted by MHLW of Japan [ and ]. In the context of the guideline, the investigators shall not necessarily be required to obtain informed consent, but we made public information concerning this study on the web [] and ensured the opportunities for the research subjects to refuse use of their personal information.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}